Lontrue Co., Ltd. (300175.SZ): Chairman voluntarily forgoes compensation; General Manager and CFO voluntarily take pay cuts.
Lontrue Co., Ltd. (300175.SZ) announced that Chairman Mr. Zhao Zheng, leading by example and taking proactive responsibility, has voluntarily forgone the compensation he would be entitled to receive under the company's compensation management system starting from October 1, 2026, demonstrating through concrete action his firm confidence in the company's long-term development prospects and his determination to stand together with the management team and all employees through thick and thin. In addition, Director and General Manager Mr. Cao Yuchen has voluntarily taken a 50% pay cut, and Director and CFO Mr. Wang Tao has voluntarily taken a 30% pay cut.
Lontrue Co., Ltd. (300175.SZ) announced that Chairman Mr. Zhao Zheng, leading by example and taking proactive responsibility, has voluntarily forgone the compensation he would be entitled to receive under the company's compensation management system starting from October 1, 2026, demonstrating through concrete action his firm confidence in the company's long-term development prospects and his determination to stand together with the management team and all employees through thick and thin. In addition, Director and General Manager Mr. Cao Yuchen has voluntarily taken a 50% pay cut, and Director and CFO Mr. Wang Tao has voluntarily taken a 30% pay cut.
Related Articles
US Stock Market Move | Alibaba Group Holding Limited Sponsored ADR (BABA.US) rose more than 6% as Apple Inc.'s intelligence features for the China market began testing, opening new opportunities for Qwen.
KPA-BM HLDGS (02663) changes controlling shareholder, receives a general offer at a discount of approximately 13.8%, trading resumes on November 5.
MICOT PHARMA-B (02335) received the first project funding under the National Science and Technology Major Project and obtained ethics approval from the lead site for the Phase III clinical trial of MT200605.
US Stock Market Move | Alibaba Group Holding Limited Sponsored ADR (BABA.US) rose more than 6% as Apple Inc.'s intelligence features for the China market began testing, opening new opportunities for Qwen.
KPA-BM HLDGS (02663) changes controlling shareholder, receives a general offer at a discount of approximately 13.8%, trading resumes on November 5.
MICOT PHARMA-B (02335) received the first project funding under the National Science and Technology Major Project and obtained ethics approval from the lead site for the Phase III clinical trial of MT200605.
